Beijing Strong Biotechnologies Inc (300406.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100001Y26

Price
12.49 CNY
Market cap
7.32 bn CNY
P/E (2025)
38.57
P/S (2025)
5.40
Dividend yield
8.41 %
Net margin
14.01 %
Return on equity (ROE)
5.01 %
Return on assets (ROA)
3.76 %

Beijing Strong Biotechnologies Inc financials

Fiscal year20242025
Revenue1.66 bn CNY1.36 bn CNY
Gross profit1.30 bn CNY1.08 bn CNY
Operating income624.05 m CNY474.78 m CNY
EBIT632.01 m CNY285.70 m CNY
Net income532.64 m CNY189.87 m CNY
Diluted EPS – continuing operations0.90 CNY0.32 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Beijing Strong Biotechnologies Inc

Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. It provides biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein S activity, protein C, lupus anticoagulant, fibrin degradation products, and d-dimer. The company also offers blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; and automatic coagulation analyzer, automatic biochemistry analyzer, fully automatic chemiluminescence immunoassay analyzer, and automated blood groupings analyzer. It sells its products under the Kingsley and Meichuang brand names. Beijing Strong Biotechnologies,Inc. was founded in 2001 and is based in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.